CorMedix (CRMD) Exchange Rate Effect (2015 - 2025)
CorMedix's (CRMD) quarterly Exchange Rate Effect came in at $276.0 in Q3 2025, down 33.49% year-on-year from $415.0 in Q3 2024, and down 66.67% quarter-over-quarter from $828.0 in Q2 2025.
CorMedix (CRMD) Exchange Rate Effect (2015 - 2025) Analysis & Trends
CorMedix has disclosed Exchange Rate Effect across 11 years of filings, most recently posting $276.0 for Q3 2025.
- Exchange Rate Effect for Q3 2025 came in at $276.0, down 33.49% year-over-year; the trailing twelve-month figure through Sep 2025 was -$189.0 (down 109.72% YoY), and the FY2024 annual result was -$2000.0, down 171.23% from the prior year.
- Exchange Rate Effect came in at $276.0 for Q3 2025 at CorMedix, down from $828.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $15787.0 in Q4 2022 to a low of -$10909.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$88.0 (2024), against an average of -$1023.9.
- Across the five-year window, Exchange Rate Effect slumped 438.75% in 2022 and jumped 1040.91% in 2025, its largest moves.
- CorMedix's Exchange Rate Effect stood at -$3120.0 in 2021, then soared by 605.99% to $15787.0 in 2022, then plunged by 84.65% to $2423.0 in 2023, then sank by 162.81% to -$1522.0 in 2024, then jumped by 118.13% to $276.0 in 2025.
- The last three Exchange Rate Effect figures came in at $276.0 (Q3 2025), $828.0 (Q2 2025), and $229.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 276.00 |
| Sep 30, 2025 | 276.00 |
| Jun 30, 2025 | 828.00 |
| Jun 30, 2025 | 828.00 |
| Mar 31, 2025 | 229.00 |
| Mar 31, 2025 | 229.00 |
| Dec 31, 2024 | -1,522.00 |
| Dec 31, 2024 | -1,522.00 |
| Sep 30, 2024 | 415.00 |
| Sep 30, 2024 | 415.00 |
| Jun 30, 2024 | -88.00 |
| Jun 30, 2024 | -88.00 |
| Mar 31, 2024 | -805.00 |
| Mar 31, 2024 | -805.00 |
| Dec 31, 2023 | 2,423.00 |
| Dec 31, 2023 | 2,423.00 |
| Sep 30, 2023 | -2,146.00 |
| Sep 30, 2023 | -2,146.00 |
| Jun 30, 2023 | 247.00 |
| Jun 30, 2023 | 247.00 |